Patents by Inventor Gregory Babcock

Gregory Babcock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
    Publication number: 20160251413
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Application
    Filed: May 16, 2016
    Publication date: September 1, 2016
    Inventors: Luke Robinson, Zachary Shriver, James R. Myette, Gregory Babcock, Karthik Viswanathan
  • Antibody molecules to dengue virus and uses thereof
    Patent number: 9365639
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: June 14, 2016
    Assignee: VISTERRA, INC.
    Inventors: Luke Robinson, Zachary Shriver, James Myette, Gregory Babcock, Karthik Viswanathan
  • ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
    Publication number: 20160046697
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Application
    Filed: October 23, 2015
    Publication date: February 18, 2016
    Inventors: Luke Robinson, Zachary Shriver, James Myette, Gregory Babcock, Karthik Viswanathan
  • Antibody molecules to dengue virus and uses thereof
    Patent number: 9212217
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: December 15, 2015
    Assignee: Visterra, Inc.
    Inventors: Luke Robinson, Zachary Shriver, James Myette, Gregory Babcock, Karthik Viswanathan
  • ANTI-SOD1 ANTIBODIES AND USES THEREOF
    Publication number: 20150322167
    Abstract: The present invention features anti-SOD1 antibodies and methods of using the antibodies for the treatment of amyotrophic lateral sclerosis (ALS) or the amelioration of symptoms associated with ALS.
    Type: Application
    Filed: July 28, 2015
    Publication date: November 12, 2015
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Donna AMBROSINO, Gregory BABCOCK, Teresa BROERING, Zuoshang XU
  • Anti-SOD1 antibodies and uses thereof
    Patent number: 9109037
    Abstract: The present invention features anti-SOD1 antibodies and methods of using the antibodies for the treatment of amyotrophic lateral sclerosis (ALS) or the amelioration of symptoms associated with ALS.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: August 18, 2015
    Assignee: University of Massachusetts
    Inventors: Donna Ambrosino, Gregory Babcock, Teresa Broering, Zuoshang Xu
  • ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
    Publication number: 20150225474
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Application
    Filed: January 20, 2015
    Publication date: August 13, 2015
    Inventors: Luke Robinson, Zachary Shriver, James Myette, Gregory Babcock
  • ANTI-SOD1 ANTIBODIES AND USES THEREOF
    Publication number: 20140044722
    Abstract: The present invention features anti-SOD1 antibodies and methods of using the antibodies for the treatment of amyotrophic lateral sclerosis (ALS) or the amelioration of symptoms associated with ALS.
    Type: Application
    Filed: October 25, 2011
    Publication date: February 13, 2014
    Applicant: University of Massachusetts
    Inventors: Donna Ambrosino, Gregory Babcock, Teresa Broering, Zuoshang Xu
  • Antibodies against Clostridium difficile toxins and uses thereof
    Publication number: 20050287150
    Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.
    Type: Application
    Filed: February 4, 2005
    Publication date: December 29, 2005
    Applicants: UNIVERSITY OF MASSACHUSETTS, MEDAREX, INC.
    Inventors: Donna Ambrosino, Gregory Babcock, Teresa Broering, Robert Graziano, Hector Hernandez, Israel Lowy, Robert Mandell, Deborah Molrine, William Thomas, Hui-Fen Zhang
  • SARS nucleic acids, proteins, antibodies, and uses thereof
    Publication number: 20050069869
    Abstract: Codon-optimized nucleic acids, polypeptides, and antibodies are described herein.
    Type: Application
    Filed: August 4, 2004
    Publication date: March 31, 2005
    Inventors: Donna Ambrosino, Hector Hernandez, Thomas Greenough, Katherine Luzuriaga, Mohan Somasundaran, Gregory Babcock, William Thomas, John Sullivan